Increased CD14 + HLA-DR -/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome
PeerJ · 2024
DOI: 10.7717/peerj.18154 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Yinsheng Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Myeloid-Derived Suppressor Cells, Biomarkers, Lipopolysaccharide Receptors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: An-hui Natural Fund General Project.
Abstract (Originalsprache)
Purpose
This study aimed to investigate the dynamic changes in monocytic myeloid-derived suppressor cells (M-MDSCs) and their implications in the pathogenesis of acute coronary syndrome (ACS), shedding light on potential therapeutic targets. Experimental Design Peripheral blood samples were collected from 68 ACS patients, 35 stable angina pectoris (SAP) patients, and 30 healthy controls (HC). Multi-parameter flow cytometry was employed for analysis of M-MDSCs, explored with disease characteristics and progression.
Results
ACS patients exhibited an increased frequency of circulating M-MDSCs compared to SAP patients and HC. M-MDSCs levels demonstrated associations with ACS type, coronary artery lesions, multi-vessel disease, and cardiac dysfunction severity. Higher M-MDSCs levels were found in obese patients. Notably, therapy led to a significant decrease in M-MDSCs frequency. Furthermore, ACS patients exhibited elevated levels of interleukin (IL)-6, IL-10, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor- α (TNF- α ) in the cytokine profile associated with M-MDSCs. Increased expression of arginase-1(Arg-1) was observed in ACS patients, with positive correlations between M-MDSCs levels and IL-6, GM-CSF, and Arg-1 expression. The diagnostic performance of triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and M-MDSCs levels varied in predicting the severity of coronary artery stenosis, with TG showing higher specificity, HDL-C displaying higher sensitivity, and M-MDSCs levels demonstrating balanced sensitivity and specificity.
Conclusions
Assessment of M-MDSCs frequency holds promise as a predictive marker for disease progression and therapy response of coronary artery stenosis. The elevated presence of M-MDSCs suggests their potential role in modulating ACS-related inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
- Department of Cardiovascular, East District of First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
- Department of Cardiovascular, Lu'an People's Hospital of Anhui Province, Lu'an, Anhui Province, China.
Förderung
- An-hui Natural Fund General Project
Zitieren
APA
Tan, Y., Ren, M., Hou, J., Hou, T., & Lin, X. (2024). Increased CD14 + HLA-DR -/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome. PeerJ. https://doi.org/10.7717/peerj.18154
Vancouver
Tan Y, Ren M, Hou J, Hou T, Lin X. Increased CD14 + HLA-DR -/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome. PeerJ. 2024. doi:10.7717/peerj.18154
BibTeX
@article{Tan2024,
author = {Tan, Yinsheng and Ren, Mingde and Hou, Jie and Hou, Tao and Lin, Xianhe},
title = {Increased CD14 + HLA-DR -/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.18154}
}
EUVIMED